| Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol (NCT03997370) | NRG Oncology | 2020-01-15 |
| Cancer Genetic Testing in Ethnic Populations (NCT04475640) | Mayo Clinic | 2020-01-13 |
| Psychotherapy (Accelerated Resolution Therapy) for Cancer Related Trauma and Distress (NCT04436835) | Mayo Clinic | 2019-11-27 |
| Development of the Oncology Opportunity Cost Assessment Tool (NCT04694911) | Thomas Jefferson University | 2019-11-21 |
| Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients (NCT04630431) | Mayo Clinic | 2019-10-15 |
| Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor (NCT04122118) | Thomas Jefferson University | 2019-09-25 |
| Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY (NCT04060849) | Fred Hutchinson Cancer Center | 2019-09-03 |
| Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy (NCT04170075) | OHSU Knight Cancer Institute | 2019-08-05 |
| Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO (NCT03816345) | National Cancer Institute (NCI) | 2019-07-16 |
| Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors (NCT03996265) | University of Rochester NCORP Research Base | 2019-06-27 |
| Yoga Program for Improving the Quality of Life in Couples Coping With Cancer (NCT04607590) | M.D. Anderson Cancer Center | 2019-05-31 |
| Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study (NCT06304168) | Mayo Clinic | 2019-05-13 |
| Ultrasound in Evaluating Muscle-Glycogen Content in Cancer Patients (NCT03982082) | M.D. Anderson Cancer Center | 2019-04-12 |
| Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies (NCT05108519) | M.D. Anderson Cancer Center | 2019-04-08 |
| Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial (NCT03892967) | Mayo Clinic | 2019-03-28 |
| Intravital Microscopy in Human Solid Tumors (NCT03823144) | Mayo Clinic | 2019-02-28 |
| EXERCISING TOGETHER for Couples Coping With Cancer (NCT03630354) | OHSU Knight Cancer Institute | 2019-01-18 |
| Patient Registry in Patients Undergoing Contrast-Enhanced Harmonic Endoscopic Ultrasound Imaging (NCT05717101) | Mayo Clinic | 2018-12-17 |
| Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer (NCT03579446) | M.D. Anderson Cancer Center | 2018-11-29 |
| Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors (NCT03750227) | Mayo Clinic | 2018-11-19 |
| Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma (NCT03610490) | M.D. Anderson Cancer Center | 2018-10-16 |
| Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G) (NCT06360588) | National Cancer Institute (NCI) | 2018-10-08 |
| Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2) (NCT06351371) | National Cancer Institute (NCI) | 2018-07-03 |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas (NCT03449108) | M.D. Anderson Cancer Center | 2018-04-27 |
| Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) (NCT03213652) | National Cancer Institute (NCI) | 2018-04-17 |
| Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery (NCT03361436) | OHSU Knight Cancer Institute | 2018-03-19 |
| Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients (NCT06015932) | Mayo Clinic | 2017-12-20 |
| Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer (NCT03223753) | Children's Oncology Group | 2017-11-29 |
| 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients (NCT03168737) | M.D. Anderson Cancer Center | 2017-09-22 |
| Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies (NCT03217747) | M.D. Anderson Cancer Center | 2017-08-02 |
| Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy (NCT03080883) | Academic and Community Cancer Research United | 2017-07-14 |
| Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors (NCT02631733) | National Cancer Institute (NCI) | 2017-05-31 |
| Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases (NCT02993146) | National Cancer Institute (NCI) | 2017-05-08 |
| Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J) (NCT06136897) | National Cancer Institute (NCI) | 2017-03-23 |
| Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery (NCT04955808) | National Cancer Institute (NCI) | 2017-02-07 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Comprehensive Nutritional Geriatric Assessments in Identifying Malnutrition in Older Cancer Participants (NCT03035604) | M.D. Anderson Cancer Center | 2017-01-24 |
| Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology (NCT02847130) | Children's Oncology Group | 2016-11-21 |
| Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version) (NCT02515383) | M.D. Anderson Cancer Center | 2016-11-09 |
| Communication Issues in Patient and Provider Discussions of Immunotherapy (NCT05873608) | Emory University | 2016-10-06 |
| Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors (NCT02717507) | Children's Oncology Group | 2016-04-04 |
| Evaluation of Satisfaction With Quality of Care on the Palliative Care Unit (NCT02686411) | M.D. Anderson Cancer Center | 2016-02-17 |
| Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer (NCT02453620) | National Cancer Institute (NCI) | 2016-02-12 |
| Project: Every Child for Younger Patients With Cancer (NCT02402244) | Children's Oncology Group | 2015-11-03 |
| Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure (NCT02464696) | M.D. Anderson Cancer Center | 2015-10-06 |
| A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study) (NCT06192875) | Mayo Clinic | 2015-09-28 |
| Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer (NCT02444741) | M.D. Anderson Cancer Center | 2015-09-17 |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors (NCT02496208) | National Cancer Institute (NCI) | 2015-07-22 |
| Stress Echocardiography to Identify Chemotherapy Induced Cardiotoxicity in Cancer Patients With Heart Failure Risk (NCT05950399) | Mayo Clinic | 2015-06-29 |
| Collection and Storage of Tissue and Blood Samples From Patients With Cancer (NCT02474160) | National Cancer Institute LAO | 2015-05-19 |
| Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection (NCT02210078) | M.D. Anderson Cancer Center | 2015-02-19 |
| Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma (NCT01989585) | National Cancer Institute (NCI) | 2014-03-24 |
| Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers (NCT02020707) | Mayo Clinic | 2014-02-24 |
| Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer (NCT01628029) | M.D. Anderson Cancer Center | 2014-01-15 |
| New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality (NCT03980535) | M.D. Anderson Cancer Center | 2012-04-16 |
| Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program (NCT01772771) | M.D. Anderson Cancer Center | 2012-03-01 |
| Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer (NCT01050504) | University of Washington | 2009-08-01 |
| Collection of Outcomes Data for Pregnant Patients With Cancer (NCT00507572) | M.D. Anderson Cancer Center | 2005-12-19 |
| Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy (NCT00991094) | M.D. Anderson Cancer Center | 2005-05-27 |